Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
|
CN |
|
Leonardo SpA
F:FMN
|
IT |
|
Environmental Packaging Technologies Holdings Inc
OTC:EPTI
|
US |
|
Vilkyskiu Pienine AB
F:UDW
|
LT |
|
Computacenter PLC
LSE:CCC
|
UK |
|
E
|
EnSync Inc
OTC:ESNC
|
US |
Intrinsic Value
Is Hubei Jumpcan Pharmaceutical Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Hubei Jumpcan Pharmaceutical Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Hubei Jumpcan Pharmaceutical Does
Hubei Jumpcan Pharmaceutical makes prescription medicines and the drug ingredients used to produce them. Its business sits in two parts of the pharmaceutical chain: it manufactures active ingredients and other pharmaceutical products, and it also sells finished drugs that end up in hospitals, pharmacies, and other healthcare channels. That means it is not just a drug marketer; it also produces the core chemical and formulation products behind those medicines.
- Headquarters
- China CN
- Employees
- 5 026
- IPO date
- Aug 22, 2001
Hubei Jumpcan Pharmaceutical has a narrow economic moat
Hubei Jumpcan Pharmaceutical Co Ltd has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Hubei Jumpcan Pharmaceutical Co Ltd
Earnings Waterfall
Hubei Jumpcan Pharmaceutical Co Ltd
The intrinsic value for Hubei Jumpcan Pharmaceutical Co Ltd (600566) under the Base Case is hidden CNY.
Compared with the current market price of 26.88 CNY, the stock appears hidden.